Hilleman signs MoU with Bangladesh firms to develop oral cholera vaccine

Hilleman Laboratories, a joint venture of Merck and Wellcome Trust, has signed a memorandum of understanding (MoU) with Bangladesh-based icddr,b and Incepta Vaccine to develop an oral cholera vaccine.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news